PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC — Stella

Recruiting

Back to Triple Negative Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Key details

Phase

Safety & dosing

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

Breast Cancer Research Foundation

Enrollment target

~30 participants

Started

May 2024

Primary completion

June 2029

Age range

18 Years and older

Sex

Female only

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov